rugosin E

structure given in first source

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

1.	Breast Neoplasms (Breast Cancer) 04/18/2007 - "In this study, we first report the chemopreventive effect of rugosin E in human breast cancer cell line, MDA-MB-231. " 04/18/2007 - "Rugosin E, an ellagitannin, inhibits MDA-MB-231 human breast cancer cell proliferation and induces apoptosis by inhibiting nuclear factor-kappaB signaling pathway."
2.	Neoplasms (Cancer) 04/18/2007 - "Our results indicated that rugosin E inhibits the activation of NF-kappaB, and this may provide a molecular basis for drug development in the prevention and treatment of cancer by rugosin E."